Research Article
Il-6 Serum Levels and Production Is Related to an Altered Immune Response in Polycystic Ovary Syndrome Girls with Insulin Resistance
Table 2
Hormonal characteristics of the study population (mean ± SD).
| | Controls | PCOS | IR | NIR |
| n | 55 | 44 | 19 | 25 | T (nmol/L) (M ± ES) | 0.4 ± 0.2* | 0.6 ± 0.4 | 0.6 ± 0.4 | 0.7 ± 0.4 | A (nmol/L) (M ± ES) | 1.7 ± 0.8* | 2.3 ± 1.0 | 2.2 ± 0.9 | 2.3 ± 1.1 | PRL (ng/mL) | 25.4 ± 8.1 | 23.1 ± 13.0 | 20.3 ± 10.6 | 26.0 ± 15.5 | LH (IU/L) (M ± ES) | 3.7 ± 1.5 | 3.9 ± 2.5 | 4.0 ± 2.1 | 3.9 ± 2.8 | FSH (IU/L) (M ± ES) | 6.1 ± 2.8 | 5.4 ± 1.6 | 5.7 ± 1.4 | 5.2 ± 1.8 | E2 (pmol/L) (M ± ES) | 17.6 ± 25.4 | 27.3 ± 26.5 | 22.6 ± 10.6 | 30.9 ± 33.7 | DHEAS (μmol/L) (M ± ES) | 1.5 ± 0.6 | 2.2 ± 1.3 | 2.2 ± 1.3 | 2.2 ± 1.3 | 17OHP (ng/mL) (M ± ES) | 1.2 ± 0.6 | 1.4 ± 1.8 | 1.1 ± 0.4 | 1.7 ± 2.4 | SHBG (nmol/L) (M ± ES) | 74.4 ± 34.7 | 66.6 ± 37.9 | 45.7 ± 24.7 | 81.4 ± 39.0 |
|
|
*
P < .05 versus IR and NIR.
|